Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
NCT01817270Phase 4Completed
- Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Start
- Mar 2013
- Primary completion
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varicella vaccine live in chickenpox, sponsored by Changchun Keygen Biological Products Co., Ltd. Primary endpoints: Seroconversion rate and Geometric Mean Titres. Started Mar 2013; status: completed.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on NCT01817270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817270.